knowledge -WSS

knowledge

author：entertainment 2025-09-03 15:25:25 - browse：65

Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

WSS

Paxlovid rebound happens. Why and to whom are still a mystery

Doctors push to include dialysis machines in emergency stockpile

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

15 die by electrocution after transformer explodes in northern India

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Robert Kennedy Jr.'s presidential campaign attracts GOP

knowledge

knowledge

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Flagship, Pfizer team up in deal worth up to $7 billion

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Google's generative AI to analyze medical images — and talk to docs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Slovenia has suffered its worst

Apple is now the first public company to be valued at $3 trillion

Failure, not just success, should guide future doctors

Bright Health sells Medicare Advantage business to Molina

Doctors push to include dialysis machines in emergency stockpile

leisure time

Flagship, Pfizer team up in deal worth up to $7 billion

Many breast cancer patients receive more radiation than needed

Pennsylvania man bitten on the head by bear during attack in his garage

'Brian's Song' at 50 still offers lessons about cancer for today

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Sweden knocks USA out of World Cup in penalty kicks

explore

hotspot

hotspot

hotspot